Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 14.90 +0.15 (+1.02%)
As of 04:18 AM Eastern

FDBK vs. COG, INHC, TRLS, IQAI, DVRG, SENS, EMIS, CRW, INS, and KOO

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Cambridge Cognition (COG), Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Feedback vs. Its Competitors

Feedback (LON:FDBK) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends.

In the previous week, Cambridge Cognition had 1 more articles in the media than Feedback. MarketBeat recorded 1 mentions for Cambridge Cognition and 0 mentions for Feedback. Cambridge Cognition's average media sentiment score of 0.67 beat Feedback's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Company Overall Sentiment
Feedback Neutral
Cambridge Cognition Positive

Cambridge Cognition has a net margin of -10.07% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -39.71% -22.99%
Cambridge Cognition -10.07%-68.83%-0.30%

53.2% of Feedback shares are owned by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are owned by institutional investors. 10.8% of Feedback shares are owned by company insiders. Comparatively, 29.9% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£3.88M1.68-£10.84M-£24.74-0.60
Cambridge Cognition£15.64M1.01-£1.58M-£3.76-9.99

Feedback received 60 more outperform votes than Cambridge Cognition when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%

Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.

Summary

Cambridge Cognition beats Feedback on 8 of the 15 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£6.53M£212.55M£5.61B£2.93B
Dividend Yield4.56%6.68%5.28%4.90%
P/E Ratio-0.60321.0327.14125.70
Price / Sales1.68255.37411.83243,028.65
Price / Cash1.1247.1438.2528.07
Price / Book0.265.387.064.71
Net Income-£10.84M-£15.55M£3.23B£5.91B
7 Day Performance2.41%-0.40%2.67%13.20%
1 Month PerformanceN/A-1.44%8.82%16.80%
1 Year Performance-77.76%2.42%31.44%78.27%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 14.90
+1.0%
N/A-78.1%£6.53M£3.88M-0.6024
COG
Cambridge Cognition
N/AGBX 37.50
-3.8%
N/A-9.1%£15.70M£15.64M-9.9780Gap Down
INHC
Induction Healthcare Group
N/AGBX 9.36
-1.5%
N/A-23.1%£8.64M£12.57M-1.6974
TRLS
Trellus Health
N/AGBX 1.20
+9.1%
N/A-41.8%£2.32M£65.83K-0.3531Gap Down
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-40.7%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
2.7737 of 5 stars
GBX 2,070
-2.4%
GBX 2,800
+35.3%
-16.7%£889.41M£230.77M76.48734News Coverage
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500Positive News
KOO
Kooth
2.1606 of 5 stars
GBX 180
+2.0%
GBX 456.67
+153.7%
-44.1%£66.07M£50.72M16.91478News Coverage

Related Companies and Tools


This page (LON:FDBK) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners